<qa>  What is the effect of TACE on the survival of patients with unresectable he- To determine whether the addition of sorafenib tosylate to transarterial chemoembolization TACE with doxorubicin-eluting beads, compared to TACE alone, prolongs progression-free survival of patients with unresectable hepatocellular carcinoma. 